Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

David Douglass

Concepts (94)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma
2
2025
72
0.990
Why?
Fibromatosis, Aggressive
1
2022
3
0.740
Why?
Adenomatous Polyposis Coli
1
2022
5
0.740
Why?
Rhabdomyosarcoma, Alveolar
1
2021
8
0.700
Why?
Li-Fraumeni Syndrome
1
2021
11
0.700
Why?
Receptors, Tumor Necrosis Factor, Member 14
1
2020
5
0.640
Why?
Proto-Oncogene Proteins c-ets
1
2020
8
0.640
Why?
Sarcoma, Ewing
1
2020
32
0.620
Why?
Tumor Suppressor Protein p53
1
2021
228
0.610
Why?
Mutation
2
2022
1338
0.590
Why?
Antineoplastic Agents
2
2025
1232
0.540
Why?
DNA-Binding Proteins
1
2020
423
0.530
Why?
Transcription Factors
1
2020
571
0.500
Why?
Soft Tissue Neoplasms
2
2025
62
0.410
Why?
Breast Neoplasms
1
2021
1223
0.370
Why?
Prognosis
3
2024
2118
0.300
Why?
Adolescent
4
2025
6912
0.270
Why?
Child, Preschool
3
2025
4164
0.240
Why?
Rhabdomyosarcoma
1
2025
13
0.230
Why?
Oncogene Proteins, Fusion
1
2025
62
0.230
Why?
Anthracyclines
1
2025
35
0.220
Why?
Decision Support Techniques
1
2025
73
0.220
Why?
Antibiotics, Antineoplastic
1
2025
84
0.220
Why?
Child
4
2025
7384
0.210
Why?
Ifosfamide
1
2024
9
0.210
Why?
Neoplasm Grading
1
2024
128
0.200
Why?
Osteoblastoma
1
2023
2
0.200
Why?
Osteoma, Osteoid
1
2023
4
0.200
Why?
Neuroblastoma
1
2023
55
0.190
Why?
Protein Kinase Inhibitors
1
2025
234
0.190
Why?
Heart Diseases
1
2025
221
0.190
Why?
Genes, APC
1
2022
4
0.190
Why?
Doxorubicin
1
2024
248
0.180
Why?
Combined Modality Therapy
1
2024
640
0.180
Why?
Humans
10
2025
53246
0.170
Why?
Survival Rate
1
2024
949
0.170
Why?
Bone Neoplasms
1
2023
188
0.170
Why?
Proto-Oncogene Protein c-fli-1
1
2020
9
0.160
Why?
RNA-Binding Protein EWS
1
2020
14
0.160
Why?
Ultrasonography, Doppler, Color
1
2020
30
0.160
Why?
Cyclin D1
1
2020
59
0.160
Why?
Neoplasm Recurrence, Local
1
2024
647
0.160
Why?
Chemotherapy, Adjuvant
1
2020
122
0.160
Why?
DNA Copy Number Variations
1
2020
117
0.150
Why?
Female
5
2025
28792
0.150
Why?
Infant
2
2025
3808
0.150
Why?
Incidence
1
2022
1085
0.140
Why?
Carboxymethylcellulose Sodium
1
2018
2
0.140
Why?
Glycerol
1
2018
19
0.140
Why?
Dry Eye Syndromes
1
2018
11
0.140
Why?
Follow-Up Studies
1
2024
2318
0.140
Why?
Gene Expression Profiling
1
2023
1112
0.140
Why?
Prospective Studies
1
2024
2412
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1043
0.140
Why?
Immunohistochemistry
1
2020
975
0.130
Why?
Treatment Outcome
3
2025
5597
0.120
Why?
Skin Neoplasms
1
2020
500
0.110
Why?
Young Adult
1
2024
4514
0.100
Why?
Magnetic Resonance Imaging
1
2020
1587
0.100
Why?
Retrospective Studies
1
2024
6821
0.090
Why?
Adult
2
2024
14541
0.080
Why?
Male
3
2025
27444
0.070
Why?
Troponin T
1
2025
13
0.060
Why?
Receptors, CXCR4
1
2025
30
0.060
Why?
Cyclophosphamide
1
2025
178
0.050
Why?
Cell Movement
1
2025
279
0.050
Why?
Fibroblasts
1
2025
363
0.050
Why?
Heterogeneous-Nuclear Ribonucleoproteins
1
2023
2
0.050
Why?
Tumor Microenvironment
1
2025
274
0.050
Why?
Polypyrimidine Tract-Binding Protein
1
2023
11
0.050
Why?
Proto-Oncogene Proteins c-fos
1
2023
60
0.050
Why?
Pilot Projects
1
2025
727
0.050
Why?
Drug Resistance, Neoplasm
1
2025
350
0.050
Why?
Predictive Value of Tests
1
2025
933
0.050
Why?
Disease Progression
1
2025
880
0.050
Why?
Age Factors
1
2025
1136
0.050
Why?
Reproducibility of Results
1
2025
1221
0.040
Why?
Cell Proliferation
1
2025
1031
0.040
Why?
Cell Line, Tumor
1
2025
1470
0.040
Why?
Risk Assessment
1
2025
1368
0.040
Why?
Transcriptome
1
2023
368
0.040
Why?
Diagnosis, Differential
1
2023
1038
0.040
Why?
Lung Neoplasms
1
2025
645
0.040
Why?
Time Factors
1
2025
2992
0.040
Why?
Viscosity
1
2018
8
0.040
Why?
Administration, Ophthalmic
1
2018
4
0.040
Why?
Tears
1
2018
13
0.040
Why?
Ophthalmic Solutions
1
2018
20
0.040
Why?
Drug Combinations
1
2018
138
0.030
Why?
Double-Blind Method
1
2018
729
0.030
Why?
Risk Factors
1
2025
4018
0.030
Why?
Infant, Newborn
1
2023
2913
0.030
Why?
Aged
1
2018
10430
0.010
Why?
Middle Aged
1
2018
13422
0.010
Why?
Douglass's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description